“…In the future, we hope to find more extensive and accurate gene features in existing studies (related to cytokines, cellular immunophenotypes, antibodies, gene susceptibility, etc. ), use artificial intelligence algorithms to define and layer diseases from clinical or laboratory parameters, and identify the phenotypes and complications of disease spectrum, including cardiogenic shock (such as MIS-C shock and Kawasaki disease shock syndrome), MAS (cytopenia and coagulation dysfunction related to cytokine storm caused by infection), Kawasaki disease (typical and complete Kawasaki disease phenotype, caused by SARS -CoV-2 or other infectious factors), and provide evidence for the formulation of treatment strategies [10]. In the future, the amount of research data should be further expanded in clinical practice, and the special method of artificial intelligence should be used to diagnose, differential diagnosis and treatment of the above diseases to serve the clinical.…”